Home    Back

Optison    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease1

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,209 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02061163
(ClinicalTrials.gov)		February 20156/2/2014Contrast-Enhanced Ultrasound in Human Crohn's DiseaseEvaluation of Contrast-Enhanced Ultrasound in Human Crohn's DiseaseCrohn's DiseaseDevice: Contrast Enhanced Ultrasound;Drug: OptisonUniversity of MichiganNULLWithdrawn10 YearsN/ABoth0Phase 1;Phase 2United States